Since elevated expression of DR6 plays a pivotal role in numerous human diseases, including Alzheimer’s disease (AD), inflammation, and autoimmune disease, it is considered to be a potential therapeutic target [9]. The gene discussed is TNFRSF21; the disease is Alzheimer disease.